SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?


To: Toni Wheeler who wrote (4258)1/4/2002 10:20:39 AM
From: TI2, TechInvestorToo  Respond to of 5665
 
Brief.com INplay : 7:36AM Immunogen (IMGN) 16.11: Co receives patent covering the preparation and purification of thiol-containing maytansinoids, such as DM1. DM1 is the lead small molecule effector drug used in the Company's Tumor-Activated Prodrug technology.